|
Reaction to EU Pharmaceutical legislation: Timely and equitable access for patients and security of supply essential for reform |
Medicines for Europe |
27 Apr 2023 |
Health & Consumers |
|
Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy |
Medicines for Europe |
03 Mar 2020 |
Health & Consumers |
|
Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition |
Medicines for Europe |
27 Oct 2022 |
Health & Consumers |
|
Pharmaceutical legislation reforms must support equitable access to medicine in Central and Eastern Europe and security of medicines supplies |
Medicines for Europe |
17 Nov 2022 |
Health & Consumers |
|
Patients should benefit from greater access under new patent package proposals |
Medicines for Europe |
28 Apr 2023 |
Health & Consumers |
|
Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver! |
Medicines for Europe |
04 Dec 2018 |
Health & Consumers |
|
Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI). |
Medicines for Europe |
28 Nov 2018 |
Health & Consumers |
|
Parliament’s balanced stand on Unitary SPC regulation rewards innovation via an efficient Unitary SPC system that protects against access to medicines delays |
Medicines for Europe |
28 Feb 2024 |
InfoSociety |
|
Parliament compromise on pharmaceutical legislation accelerates much needed reform |
Medicines for Europe |
19 Mar 2024 |
Health & Consumers |
|
Orphan and paediatric reform should strive to improve access to medicine for rare disease patients and children |
Medicines for Europe |
30 Jul 2021 |
Health & Consumers |
|
Open borders that prioritise essential goods key to medicines supply in Europe |
Medicines for Europe |
02 Jun 2021 |
Health & Consumers |
|
Oncology, the new era for biosimilar medicines |
Medicines for Europe |
08 Sep 2017 |
Health & Consumers |
|
Off-patent medicines ready to drive pharma policy reform for equitable access, availability and security of medicines supply |
Medicines for Europe |
15 Jun 2023 |
Health & Consumers |
|
Off patent medicines essential for a fairer, healthier, and sustainable Europe says President Christoph Stoller |
Medicines for Europe |
30 Apr 2021 |
Health & Consumers |
|
Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing |
Medicines for Europe |
07 Oct 2020 |
Health & Consumers |
|
Now or never: Europe must seize the Pharma Legislation opportunity to ensure patient access to continuous innovation for existing medicines |
Medicines for Europe |
07 Nov 2023 |
Health & Consumers |
|
No further excuse to delay digital regulatory infrastructure for medicines after COVID-19 pandemic |
Medicines for Europe |
19 Feb 2021 |
Health & Consumers |
|
New safeguards for patient safety as Falsified Medicines Directive comes into force |
Medicines for Europe |
11 Feb 2019 |
Health & Consumers |
|
New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability |
Medicines for Europe |
01 Mar 2021 |
Health & Consumers |
|
New report assesses progress on biosimilar medicine policies across Europe |
Medicines for Europe |
30 Mar 2021 |
Health & Consumers |
|
Medicines for Europe, APOGEN and Fresenius Kabi hold Open Industry Day in Portugal |
Medicines for Europe |
14 Nov 2019 |
Health & Consumers |
|
Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines. |
Medicines for Europe |
30 Nov 2018 |
Health & Consumers |
|
Medicines for Europe warns strongly against energy rationing for medicines production |
Medicines for Europe |
20 Jul 2022 |
Health & Consumers |
|
Medicines for Europe to join the ISPOR Issue Panel on value added medicines |
Medicines for Europe |
05 Oct 2017 |
Health & Consumers |
|
Medicines for Europe statement on COVID-19 (‘coronavirus’) |
Medicines for Europe |
13 Mar 2020 |
Health & Consumers |
|
Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community |
Medicines for Europe |
22 Jun 2018 |
Health & Consumers |
|
Medicines for Europe joins the Antimicrobial (AMR) One Health Network |
Medicines for Europe |
09 May 2023 |
Health & Consumers |
|
Medicines for Europe can contribute much more to improve healthcare sustainability than described in the OECD “Health at a Glance 2016” report |
Medicines for Europe |
24 Nov 2016 |
Health & Consumers |
|
Medicines for Europe calls for greater cooperation on value added medicines to improve patient-centric innovation |
Medicines for Europe |
22 Nov 2017 |
Health & Consumers |
|
Medicines for Europe announces new President, launches Access to Medicines campaign |
Medicines for Europe |
10 Oct 2017 |
Health & Consumers |
